Bottom line
Is COVAX a good fund? The bottom line
COVAX is a share class of Columbia Small Cap Value and Inflection Fund, an actively managed small-cap mutual fund from Columbia Threadneedle.
Annual fees run 1.2% — about $120 a year on every $10,000 invested, more expensive than 70% of small-cap funds we track.
It returned +1.7% over one year, +8.2% a year over five years, +8.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $868 million in net assets and 102 holdings, its largest position is Phillips Edison & Co Inc (2.0%) and the top 10 make up 17.1% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What to watch
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
- High turnover (115% a year) can mean more taxable distributions
Updated Nov 19, 2026
What COVAX invests in
Columbia Small Cap Value and Inflection Fund (the Fund) seeks long-term capital appreciation.
Under normal circumstances, the Fund invests at least 80% of its net assets ( plus the amount of any borrowings for investment purposes) in equity securities of companies that have market capitalizations in the range of the companies in the Russell 2000 Value Index (the Capitalization Index) , which ranged between $ 10.7 million and $ 23.5 billion as of May 31, 2026 , that the Fund ' s investment manager believes are undervalued and have the potential for long-term growth. The market capitalization range and composition of companies in the Capitalization Index are subject to change. As such, the size of the companies in which the Fund invests may change. The Fund may continue to hold a security even if the companys market capitalization is no longer within the range of the Capitalization Index. Under normal circumstances, the Fund also invests at least 80% of its net assets (plus the…
From the fund's prospectus (filed Jun 25, 2026).
COVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| COVAX | +1.7% | +8.2% | +8.2% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What COVAX costs
On a $10,000 investment, COVAX's 1.2% expense ratio costs about $120 a year. The prospectus estimates $2,113 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
COVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Phillips Edison & Co Inc | 2.04% |
| 2 | StoneX Group Inc | 1.79% |
| 3 | Polaris Inc | 1.77% |
| 4 | Commercial Metals Co | 1.75% |
| 5 | BankUnited Inc | 1.70% |
| 6 | Texas Capital Bancshares Inc | 1.66% |
| 7 | Fulton Financial Corp | 1.62% |
| 8 | Synaptics Inc | 1.60% |
| 9 | Cabot Corp | 1.59% |
| 10 | Essent Group Ltd | 1.53% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 17.1% of the fund. See all top 25 holdings and asset mix →
Alternatives to COVAX
COVAX FAQ
What is the expense ratio of COVAX?
Is COVAX a good investment?
What does COVAX hold?
What is COVAX's 5-year return?
Does COVAX have a sales load?
Who manages COVAX?
Other share classes of Columbia Small Cap Value and Inflection Fund
- CRRYX · Columbia Small Cap Value and Inflection Fund Institutional 3 Class · 0.75%
- NSVAX · Columbia Small Cap Value and Inflection Fund Institutional Class · 0.95%
- CCTRX · Columbia Small Cap Value and Inflection Fund Class R · 1.45%
- CRRRX · Columbia Small Cap Value and Inflection Fund Institutional 2 Class · 0.8%
- NSVBX · Columbia Small Cap Value and Inflection Fund Class S · 0.95%